Doctor profile · Federal record

Dr. Christine Kilcline, M.D.

Procedural Dermatology Physician (CMS: Dermatology) · Pediatric Dermatology Physician · San Luis Obispo, CA

  • NPI 1093724791
  • Accepts Medicare
  • MIPS 13.9 / 100 · 2023
  • 28 yrs in practice
  • Female
  • Solo practice
  • No sanctions

Practice & contact

Operates at 2 locations .

NPPES Updated May 11, 2026
Primary practice
892 Aerovista Pl Ste 120
San Luis Obispo, CA 934018054
(805) 544-5567
fax (805) 544-3265
Additional location
525 Plaza Dr Ste 200
Santa Maria, CA 934546954

Credentials & registration

NPPES · NUCC
NPI registered
August 2006 — 20 yrs on file
Profile last updated
July 15, 2025
Year of graduation
1998 — 28 yrs since
Specialty taxonomy
207NS0135X — NUCC code
State license (1)
California #A72400

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1093724791. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
38,308
Distinct HCPCS
10
Medicare allowed
$645,606
HCPCS Description Services Patients Avg allowed
J7345 Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg 30,600 122 $2
17003 Destruction of precancer skin growth, 2-14 growths 2,286 477 $7
99213 Established patient office or other outpatient visit, 20-29 minutes 1,776 1,218 $93
17000 Destruction of precancer skin growth, 1 growth 819 633 $58
17110 Destruction of skin growth, 1-14 growths 665 480 $121
11102 Biopsy of related skin growth, first growth 479 394 $99
99214 Established patient office or other outpatient visit, 30-39 minutes 477 341 $132
99212 Established patient office or other outpatient visit, 10-19 minutes 275 231 $59
99203 New patient office or other outpatient visit, 30-44 minutes 181 181 $116
96573 Application of light by qualified health care professional to destroy precancer skin growth 123 103 $254

In context: peer comparison

Among 1 peers in this city , average services per provider: 1,320. This provider delivers 29× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$1,931
Transactions
64
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Lilly USA, LLC 14 $332.18
ABBVIE INC. 13 $311.62
PFIZER INC. 5 $200.71
Galderma Laboratories, L.P. 4 $187.06
E.R. Squibb & Sons, L.L.C. 3 $153.03
Organogenesis Inc. 1 $122.34
REVANCE THERAPEUTICS, INC. 4 $95.36
MERZ NORTH AMERICA, INC. 4 $92.30
Janssen Biotech, Inc. 3 $87.52
Biofrontera Inc. 3 $83.24
UCB, Inc. 2 $80.59
Novartis Pharmaceuticals Corporation 3 $70.76
Arcutis Biotherapeutics, Inc. 3 $53.71
SUN PHARMACEUTICAL INDUSTRIES INC. 1 $25.65
Amgen Inc. 1 $21.82

By nature of payment

Food and Beverage
$1,931

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
234
Patients
125
Total drug cost
$88,571
Drug Type Claims Patients Total cost
Fluorouracil Generic 51 47 $4,031
Triamcinolone Acetonide Generic 37 24 $383
Clobetasol Propionate Generic 30 21 $2,707
Ketoconazole Generic 24 14 $491
Hydrocortisone Generic 21 19 $99
Metronidazole Generic 19 0 $1,887
Doxycycline Hyclate Generic 17 0 $850
Spironolactone Generic 12 0 $135
Taltz Autoinjector (Ixekizumab) Brand 12 0 $77,595
Imiquimod Generic 11 0 $390

Frequently asked questions

Auto-generated from federal data
What is Dr. Christine Kilcline's medical specialty?
Dr. Christine Kilcline practices Procedural Dermatology Physician in San Luis Obispo, CA.
Where does Dr. Christine Kilcline practice?
Dr. Christine Kilcline practices at 892 Aerovista Pl Ste 120, San Luis Obispo, CA 934018054. Office phone: 8055445567.
What is Dr. Christine Kilcline's NPI?
Dr. Christine Kilcline's National Provider Identifier (NPI) is 1093724791, issued by NPPES.
Does Dr. Christine Kilcline accept Medicare assignment?
Yes. Dr. Christine Kilcline accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Christine Kilcline commonly perform?
Top Medicare-reported procedures in 2023: Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg (HCPCS J7345); Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213). Source: CMS Medicare Physician & Other Practitioners file.